These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro thrombogenicity tests of factor IX concentrates. I. A survey of available assays. Prowse CV, Chirnside A, Elton RA. Thromb Haemost; 1980 Feb 29; 42(5):1355-67. PubMed ID: 6768149 [Abstract] [Full Text] [Related]
6. Spectrophotometric determination of factor Xa generation in factor IX concentrates. Pepper DS, Banhegyi D, Howie A. Thromb Haemost; 1977 Jun 30; 37(3):535-40. PubMed ID: 578033 [Abstract] [Full Text] [Related]
7. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety. Herring SW, Abildgaard C, Shitanishi KT, Harrison J, Gendler S, Heldebrant CM. J Lab Clin Med; 1993 Mar 30; 121(3):394-405. PubMed ID: 8445288 [Abstract] [Full Text] [Related]
8. The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbits. Giles AR, Nesheim ME, Hoogendoorn H, Tracy PB, Mann KG. Blood; 1982 Feb 30; 59(2):401-7. PubMed ID: 7034817 [Abstract] [Full Text] [Related]
12. Measurement of activated factor IX in factor IX concentrates: correlation with in vivo thrombogenicity. Gray E, Tubbs J, Thomas S, Oates A, Boisclair M, Kemball-Cook G, Barrowcliffe TW. Thromb Haemost; 1995 Apr 30; 73(4):675-9. PubMed ID: 7495077 [Abstract] [Full Text] [Related]
15. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin. Meddahi S, Bara L, Fessi H, Samama MM. Blood Coagul Fibrinolysis; 2000 Jan 30; 11(1):51-9. PubMed ID: 10691099 [Abstract] [Full Text] [Related]